| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |